Advertisement
Advertisement

CRBP

CRBP logo

Corbus Pharmaceuticals Holdings, Inc.

7.83
USD
Sponsored
+0.44
+5.91%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

7.97

+0.15
+1.89%

CRBP Earnings Reports

Positive Surprise Ratio

CRBP beat 21 of 40 last estimates.

53%

Next Report

Date of Next Report
Mar 09, 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.70M
/
-$1.66
Implied change from Q3 25 (Revenue/ EPS)
--
/
-12.63%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+112.82%

Corbus Pharmaceuticals Holdings, Inc. earnings per share and revenue

On Nov 12, 2025, CRBP reported earnings of -1.90 USD per share (EPS) for Q3 25, missing the estimate of -1.74 USD, resulting in a -9.11% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.39% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of -1.66 USD, with revenue projected to reach 1.70 million USD, implying an decrease of -12.63% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Corbus Pharmaceuticals Holdings, Inc. reported EPS of -$1.90, missing estimates by -9.11%, and revenue of $0.00, 0% as expectations.
The stock price moved up 7.39%, changed from $10.42 before the earnings release to $11.19 the day after.
The next earning report is scheduled for Mar 09, 2026.
Based on 12 analysts, Corbus Pharmaceuticals Holdings, Inc. is expected to report EPS of -$1.66 and revenue of $1.70M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement